Pharmacogenetics-Based versus Conventional Dosing of Warfarin: A Meta-Analysis of Randomized Controlled Trials

BACKGROUND: Recently, using the patient’s genotype to guide warfarin dosing has gained interest; however, whether pharmacogenetics-based dosing (PD) improves clinical outcomes compared to conventional dosing (CD) remains unclear. Thus, we performed a meta-analysis to evaluate these two strategies. M...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Changcheng, Yan, Wei, Wang, Gang, Wang, Fei, Li, Qingyu, Lin, Nengming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4682655/
https://www.ncbi.nlm.nih.gov/pubmed/26672604
http://dx.doi.org/10.1371/journal.pone.0144511

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4682655/
https://www.ncbi.nlm.nih.gov/pubmed/26672604
http://dx.doi.org/10.1371/journal.pone.0144511

Ejemplares similares